Can the prior authorization form be signed electronically?

Yes. Electronic signatures are generally legally valid under the ESIGN Act (15 U.S.C. §7001) and UETA when intent, consent, attribution, and retention requirements are met.

What constitutes sufficient clinical justification?

Provide diagnosis, prior therapies with dates, objective findings, relevant lab or imaging results, and why standard treatment is unsuitable; attach chart excerpts to support the request.

Where should completed forms be submitted?

Submit via the plan or PBM prior authorization portal or the secure fax/email channel identified on the member’s ID card; follow the payer’s published routing instructions.

How should urgent requests be documented?

Mark the request as expedited and include documentation of clinical urgency; follow plan-specific expedited review criteria and clearly note the adverse consequence of delay.

What happens if an authorization is denied?

The plan must provide a denial reason and appeal instructions; collect additional records and follow the plan’s appeals process to request reconsideration.

Is PHI protected when using eSignature services?

Yes when the vendor provides HIPAA-compliant controls and a signed BAA; ensure encryption, access controls, and audit logs are in place per 45 CFR §164.308 and §164.530.

Electronic Signature
Templates
Healthcare
Medco Health Medicare Part D Prior Authorization Form

Medco Health Medicare Part D Prior Authorization Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Medicare Part D Prior Authorization Request Form

Please complete both pages and return to Medco by fax at 1-800-837-0959.

Please indicate if you are requesting urgent processing Yes

If yes, state rationale for urgent processing:

If you have any questions, you may contact us toll-free at 1-800-753-2851.

PATIENT INFORMATION

First and Last Name:

Date of Birth: Telephone:

Medco Member ID Number:

Street Address:

City: State: Zip:

MEDICATION (that requires a coverage review)

Drug Name and Strength: Qty:

Directions (SIG.):

Diagnosis:

PRESCRIBER INFORMATION

First and Last Name:

Street Address:

City: State: Zip:

SECURE Fax: Telephone:

SECTION A: PLEASE ANSWER ALL OF THE FOLLOWING QUESTIONS

1. Has your patient experienced INTOLERANCE or is INTOLERANCE SUSPECTED with any of the preferred alternatives?

Yes No

2. Has your patient experienced THERAPEUTIC FAILURE with any of the preferred alternatives or would failure be suspected with any of the preferred alternatives?

Yes No

3. Is this patient UNABLE TO USE the preferred alternative(s) because of DOSAGE FORM?

Yes No

4. Are there any preferred alternative(s) that can be used to treat this patient or patient's condition?

Yes No

5. Is a greater drug quantity necessary to achieve the prescribed dose?

Yes No

6. Is a greater quantity of medication needed to accommodate the frequency of use?

Yes No

PLEASE RE-ENTER THE FOLLOWING INFORMATION ONTO THIS PAGE

PATIENT INFORMATION

First and Last Name:

Medco Member ID Number:

MEDICATION (that requires a coverage review)

Drug Name and Strength:

Diagnosis:

SECTION B: PLEASE ANSWER ALL OF THE FOLLOWING QUESTIONS

1. Is the prescriber a Medicare-participating prescriber?

Yes No

2. Is this patient currently enrolled in Part B coverage?

Yes No Unknown

3. Has coverage been denied under the Part B benefit?

Yes No Unknown/pending

4. If YES to question 3, has Part B coverage of this medication been denied because of determination of lack of medical necessity?

Yes No

5. If YES to question 3, has Part B coverage of this medication been denied because of member ineligibility?

Yes No

SECTION C: COMPLETE IF APPLICABLE: PATIENTS USING IMMUNOSUPPRESSANT MEDICATIONS

1. Is the immunosuppressant medication being used subsequent to a transplant?

Yes No

If you answered YES to question 1, please proceed to questions 2 and 3.

2. Did the transplant occur at a Medicare-approved facility?

Yes No

In accordance with CMS Immunosuppressive Drugs Policy Article (A25366), effective July 2008 Medicare Part B will cover immunosuppressant agents when used for a transplant if the beneficiary was enrolled in Part A at the time of the transplant and the transplant occurred at a Medicare-approved facility, whether or not Medicare Part A made payments for the transplant.

3. Was the patient enrolled in Medicare Part A at the time of the transplant?

Yes No

SECTION D: COMPLETE IF APPLICABLE: PATIENTS USING CHEMOTHERAPY AGENTS

1. Is the patient currently receiving or has the patient previously received the prescribed chemotherapy agent?

Yes No

SECTION E: IF APPLICABLE, PLEASE PROVIDE ADDITIONAL RATIONALE BELOW

Prescriber's Signature:

Additional Rationale

Signature Section

FAX COMPLETED FORM TO 1-800-837-0959. (Please do not send with a cover sheet.)

What this Medco Health Medicare Part D Prior Authorization Form is

The Medco Health Medicare Part D Prior Authorization Form is a standardized clinical request used by prescribers and pharmacies to seek coverage for prescription drugs that Medicare Part D plans designate as requiring prior authorization. The form collects patient identification, plan membership, prescriber credentials, medication details, diagnosis codes, and clinical justification so the pharmacy benefit manager can review clinical necessity. Proper completion supports coverage decisions, reduces processing delays, and documents the clinical reasoning that Medicare Part D sponsors and their delegated vendors require for utilization management.

Why completing the form carefully matters

A complete, accurate prior authorization form reduces claims denials, speeds access to therapy, and provides a documented clinical record for coverage decisions. Clear clinical justification and correct member identifiers help the plan assess medical necessity efficiently.

Who typically completes and relies on this form

Primary users include clinicians initiating requests and pharmacy staff managing coverage submissions.

Prescribers and clinical staff who supply diagnoses, treatment history, and signatures for medical necessity.
Pharmacists and pharmacy technicians who transmit the request and confirm member eligibility and fill instructions.
Care coordinators and caregivers who monitor decisions, obtain additional records, or prepare appeals if needed.

Secondary users include patient caregivers and benefits coordinators who track status and appeals.

Step-by-step: complete and submit a prior authorization

Follow these sequential steps to prepare a complete Medco Health Medicare Part D prior authorization request.

01

Gather records: Collect recent notes, labs, and prior therapy documentation.
02

Complete form: Enter member ID, DOB, drug details, NPI, and clinical rationale.
03

Attach support: Include relevant records in PDF or electronic format.
04

Submit: Send via the plan portal, secure fax, or pharmacy network per plan instructions.

Typical electronic submission setup

Configure your workflow to match the plan’s accepted channels and required attachments for faster processing.

Field	Configuration
Electronic Portal	Use the payer or PBM prior authorization web portal when available
Fax Submission	Secure fax with a cover sheet and document control number
EHR Integration	Transmit structured data and PDFs via e-prescribing or EHR module
Attachments Required	Include clinical notes, lab results, prior therapy documentation

How the submission and review process works

This sequence describes how a completed form moves from sender to decision and back to the care team.

Submit request: Sender uploads form and attachments to plan or PBM portal.
Intake review: Administrator confirms member eligibility and completeness of submission.
Clinical review: Reviewer assesses medical necessity against plan criteria.
Decision communicated: Plan notifies prescriber, pharmacy, and member of outcome.

Technical considerations for electronic completion

Ensure documents meet format, authentication, and privacy requirements before e-submission.

Supported formats: PDF, DOCX, HTML, Excel
Authentication: Email, SMS, or identity proofing methods
Integrations: Salesforce, NetSuite, Microsoft 365, Google Workspace

Key components found on a professional prior authorization form

A complete form organizes identification, clinical data, treatment history, prescriber credentials, attachments, and signature areas to support an efficient review.

Patient Identifiers

Member name, DOB, Medicare Member ID, and contact details needed to match eligibility records and link to pharmacy claims.

Prescriber Details

Prescriber name, NPI, specialty, phone, and facility to verify authority to prescribe and enable clarifying questions.

Medication Profile

Requested drug, strength, dosage schedule, quantity, and directions to allow precise benefit and safety assessment.

Clinical Rationale

Diagnosis, duration of condition, prior treatments and outcomes, and specific reasons standard therapy is unsuitable.

Supporting Attachments

Recent clinic notes, lab results, imaging reports, and evidence cited to substantiate medical necessity for review.

Signature Block

Prescriber signature, date, and contact; electronic signatures accepted when compliant with ESIGN/UETA standards.

Security and compliance elements to check

Encryption: TLS 1.2/1.3 in transit

Data at rest: AES‑256 encryption

HIPAA: BAA required for PHI

ESIGN / UETA: Legal e-signature frameworks

Audit trail: Timestamps and signer logs

Certifications: SOC 2 Type II and ISO 27001

Common issues that delay prior authorization decisions

Missing or incorrect Medicare Member ID stops automated verification and requires manual follow-up with the plan.
Insufficient clinical justification such as missing trial dates or prior therapy details often triggers denials or requests for more information.
Attachments in unreadable formats or scans with missing pages cause intake teams to mark the submission incomplete.
Using an outdated form version or submitting to the wrong plan channel results in routing delays and resubmission.

Risks of incorrect or incomplete submissions

Denied coverage: Claims may be denied

Treatment delay: Therapy start delayed

Patient cost: Higher out‑of‑pocket charges

Audit exposure: Record requests by CMS

Appeal workload: Additional administrative burden

Data errors: Inaccurate claims reporting

Timing considerations and typical submission expectations

Plan timetables vary; submit before medication start and allow the plan time to request additional records if needed.

Before therapy begins:

Submit the request prior to medication initiation when possible.

Allow review time:

Plan may request clarifying records before deciding.

Expedited requests:

Document urgent clinical need per plan criteria for faster consideration.

Appeals timeframe:

Follow plan instructions for filing an appeal after denial.

Record retention:

Keep submission and decision records for compliance and audit support.

Key processing milestones from submission to decision

Track these milestones so you can follow up proactively and meet plan requirements during review.

01

Submission Received

Intake logs and confirms completeness of the request.

02

Clinical Triage

Reviewer scopes medical records and determines needed clarifications.

03

Medical Review Decision

Plan issues approval, partial approval, or denial based on criteria.

04

Notification Sent

Decision communicated to prescriber, pharmacy, and member.

eSignature vendor comparison for prior authorization workflows

Compare common eSignature plans and features relevant to healthcare prior authorization: starting price, trial availability, bulk send, audit trail, and HIPAA support.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently asked questions and practical answers

Answers to common questions about e-signing, clinical justification, submission routing, and data protection for Part D prior authorizations.

Need help? Contact support

Can the prior authorization form be signed electronically?
Yes. Electronic signatures are generally legally valid under the ESIGN Act (15 U.S.C. §7001) and UETA when intent, consent, attribution, and retention requirements are met.
What constitutes sufficient clinical justification?
Provide diagnosis, prior therapies with dates, objective findings, relevant lab or imaging results, and why standard treatment is unsuitable; attach chart excerpts to support the request.
Where should completed forms be submitted?
Submit via the plan or PBM prior authorization portal or the secure fax/email channel identified on the member’s ID card; follow the payer’s published routing instructions.
How should urgent requests be documented?
Mark the request as expedited and include documentation of clinical urgency; follow plan-specific expedited review criteria and clearly note the adverse consequence of delay.
What happens if an authorization is denied?
The plan must provide a denial reason and appeal instructions; collect additional records and follow the plan’s appeals process to request reconsideration.
Is PHI protected when using eSignature services?
Yes when the vendor provides HIPAA-compliant controls and a signed BAA; ensure encryption, access controls, and audit logs are in place per 45 CFR §164.308 and §164.530.

Explore Templates

Financing Statement Amendment Addendum

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now